Tag: GEMINI

Paramagnetic rim lesions predict effectiveness of tolebrutinib

Presented By
Dr Jiwon Oh, University of Toronto, Canada
Trial
HERCULES, GEMINI
Conference
ACTRIMS 2025
Type
News article

28 March 2025 11:34

Meet the Trialist: Dr Jiwon Oh

Expert
Dr Jiwon Oh, St Michael’s Hospital, University of Toronto, Canada
Conference
ACTRIMS 2025

5 March 2025 10:59

Imsidolimab potential future therapeutic avenue for generalised pustular psoriasis

Presented By
Prof. Adam Reich, University of Rzeszów, Poland
Trial
Phase 3, GEMINI-1; GEMINI-2
Conference
EADV 2024
Type
Peer-reviewed article

6 November 2024 13:04

Vedolizumab treatment persistence and safety

Presented By
Dr S. Danese & Dr N.A. Cohen, Humanitas University, Milan, Italy
Trial
GEMINI
Conference
ECCO 2020
Type
Peer-reviewed article

14 April 2020 14:04

Vedolizumab: Results from the GEMINI programme

Trial
Phase 3, GEMINI
Conference
ECCO 2019
Type
Peer-reviewed article

9 May 2019 21:59

Vedolizumab in anti-TNF-naïve IBD patients and safety profile

Trial
GEMINI
Conference
ECCO 2018
Type
Peer-reviewed article

28 May 2018 23:04
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com